Actuated Medical
Medical device company developing motion-enabled devices for brain access, GI endoscopy, and critical care, leveraging additive manufacturing for rapid prototyping and custom production.
- CEO / Founder
- Maureen L. Mulvihill, Ph.D.
- Team Size
- 11-50
- Stage
- Established
- Total Funding
- $36.3M
- Latest Round
- Venture Round
- Key Investors
- Keiretsu Forum; Ben Franklin Technology Partners; Mid-Atlantic Investor Summit
Technology & Products
Key Products
TubeClear® System (clearing feeding tubes); Neural implant inserters for brain access; GripTract-GI (endoscopic tissue retractor); Face shields (produced during COVID-19 pandemic)
Technological Advantage
Proprietary motion control technology combined with additive manufacturing for rapid prototyping and custom device production, protected by a strong IP portfolio (26 US patents, 16 international patents). The company is ISO 13485 certified, MDSAP compliant, and FDA registered, with 9 FDA 510(k) clearances.
Differentiation
Value Proposition
Reduces procedure time and improves patient outcomes through precision motion-controlled devices; additive manufacturing enables rapid customization and iteration, reducing time-to-market for custom medical devices.
How They Differentiate
Focus on motion-enabled devices for specific clinical needs (neural, GI, airway) with a strong IP portfolio and additive manufacturing capabilities for customization, unlike general medical device competitors.
Market & Competition
Target Customers
Hospitals, surgeons, clinical institutions, and contract manufacturing clients
Industry Verticals
Medical Devices; Healthcare
Competitors
Forerunner Medical; DUKE Empirical; Canadian Hospital Specialties
Growth & Milestones
Growth Metrics
Two FDA-cleared devices; shipped first clinical supplies for GripTract-GI; 3 clinical trials; 4 news; 1 literature
Major Milestones
First shipment of GripTract-GI clinical supplies (2026); Received Vizient Innovative Technology contract for TubeClear System; NASA I-Corps Bootcamp participant (2018); Shifted to produce face shields during COVID-19 pandemic (2020); Awarded Frank Baldino Bioscience CEO of the Year (2020)
Notable Customers
NASA; Mayo Clinic; Penn State University